Skip to main content
SpringerLink
Log in

Genetic thrombophilia in patients with retinal vascular occlusion

  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Background: This study was carried out to determine the prevalence of genetic thrombophilia in patients with retinal vascular occlusion.Methods: We investigated 116 consecutive patients with central retinal vein occlusion (CRVO, n = 48), branch retinal vein occlusion (BRVO, n = 33), central retinal artery occlusion (CRAO, n = 21), branch retinal artery occlusion (BRAO, n = 14). All patients underwent comprehensive tests for coagulation disorders including determinations of protein C, protein S, lupus anticoagulants, prothrombin gene mutation (G20210A), resistance to activated protein C (APCR), and were screened for vascular disease risk factors. APC resistance was confirmed by a PCR method to detect the factor V R506Q mutation. A PCR method was also used to detect the G20210A mutation. For comparative purposes, we screened 209 consecutive patients with deep vein thrombosis (DVT) and 581 patients with coronary heart disease (control group) for APC resistance.Results: 13 (27%) of 48 patients with CRVO had the factor V R506Q mutation. The factor V R506Q mutation was detected in six (18%) of 33 patients with BRVO, but in only one patient with CRAO and in two patients with BRAO. Other thrombophilic defects were not detected. The APCR prevalence within the CRVO group was significantly increased when compared to the control group (8%). There was no significant difference in the factor V R506Q mutation prevalence between the CRVO group and the DVT group (19%).Conclusion: The factor V R506Q mutation is the most commoncause of genetic thrombophilia in patients with CRVO and has a similar prevalence as in DVT patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abt K. Descriptive data analysis: a concept between confirmatory and exploratory data analysis. Methods Inf Med 1987; 26: 77–88.

    Google Scholar 

  2. Appleby RD, Olds RJ. The inherited basis of venous thrombosis. Pathology 1997; 29: 341–7.

    Google Scholar 

  3. Arruda VR, Annichino-Bizzacchi JM, Goncalves MS, Costa FF. Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease. Thromb Haemost 1997; 78: 1430–3.

    Google Scholar 

  4. Bandello F, Vigano DS, Parlavecchia M, Tavola A, Della VP, Brancato R et al. Hypercoagulability and high lipoprotein(a) levels in patients with central retinal vein occlusion. Thromb Haemost 1994; 72: 39–43.

    Google Scholar 

  5. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de RH, van-der VP, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64–7.

    Google Scholar 

  6. Bertina RM, Rosendaal FR. Venous thrombosis- the interaction of genes and environment. N Engl J Med 1998; 338: 1840–1.

    Google Scholar 

  7. Chan LC, Bourke C, Lam CK, Liu HW, Brookes S, Jenkins V et al. Lack of activated protein C resistance in healthy Hong Kong Chinese blood donors- correlation with absence of Arg506-Gln mutation of factor V gene. Thromb Haemost 1996; 75: 522–3.

    Google Scholar 

  8. Dahlbäck B. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis. J Intern Med Suppl 1997; 740: 1–8.

    Google Scholar 

  9. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004–8.

    Google Scholar 

  10. Demarmels-Biasiutti F., Merlo C, Furlan M, Sulzer I, Binder BR, Lammle B. No association of APC resistance with myocardial infarction. Blood Coagul Fibrinolysis 1995; 6: 456–9.

    Google Scholar 

  11. Dodson PM, Clough CG, Downes SM, Kritzinger EE. Does type II diabetes predispose to retinal vein occlusion? Eur J Ophthalmol 1993; 3: 109–13.

    Google Scholar 

  12. Fujimura H, Kambayash J, Monden M, Kato H, Miyata T. Coagulation factor V Leiden mutation may have a racial background. Thromb Haemost 1995; 74: 1381–2.

    Google Scholar 

  13. Glueck CJ, Bell H, Vadlamani L, Gupta A, Fontaine RN, Wang P et al. Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion. Arch Ophthalmol 1999; 117: 43–9.

    Google Scholar 

  14. Hainaut P, Azerad MA, Lehmann E, Schlit AF, Zech F, Heusterspreute M et al. Prevalence of activated protein C resistance and analysis of clinical profile in thromboembolic patients. A Belgian prospective study. J Intern Med 1997; 241: 427–33.

    Google Scholar 

  15. Hillarp A, Zoller B, Svensson PJ, Dahlbäck B. The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thromb Haemost 1997; 78: 990–2.

    Google Scholar 

  16. Hodgkins PR, Perry DJ, Sawcer SJ, Keast BJ. Factor V and antithrombin gene mutations in patients with idiopathic central retinal vein occlusion. Eye 1995; 9: 760–2.

    Google Scholar 

  17. Iijima H, Gohdo T, Imai M, Tsukahara S. Thrombinantithrombin III complex in acute retinal vein occlusion. Am J Ophthalmol 1998; 126: 677–82.

    Google Scholar 

  18. Jorquera JI, Montoro JM, Fernandez MA, Aznar JA. Modi-fied test for activated protein C resistance. Lancet 1994; 344: 1162–3.

    Google Scholar 

  19. Kontula K, Ylikorkala A, Miettinen H, Vuorio A, Kauppinen MR, Hamalainen L et al. Arg506Gln factor V mutation (factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction. Thromb Haemost 1995; 73: 558–60.

    Google Scholar 

  20. Koster T, Rosendaal FR, de RH, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503–6.

    Google Scholar 

  21. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V et al. Inherited thrombophilia: Part 1. Thromb Haemost 1996a; 76: 651–62.

    Google Scholar 

  22. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V et al. Inherited thrombophilia: Part 2. Thromb Haemost 1996; 76: 824–34.

    Google Scholar 

  23. Larsson J, Olafsdottir E, Bauer B. Activated protein C resistance in young adults with central retinal vein occlusion. Br J Ophthalmol 1996; 80: 200–2.

    Google Scholar 

  24. Lindblad B, Svensson PJ, Dahlbäck B. Arterial and venous thromboembolism with fatal outcome and resistance to activated protein C. Lancet 1994; 343: 917.

    Google Scholar 

  25. Linna T, Ylikorkala A, Kontula K, Puska P, Tervo T. Prevalence of factor V Leiden in young adults with retinal vein occlusion. Thromb Haemost 1997; 77: 214–6.

    Google Scholar 

  26. Makris M, Rosendaal FR, Preston FE. Familial thrombophilia: genetic risk factors and management. J Intern Med 1997; Suppl 740: 9–15.

    Google Scholar 

  27. Marzo C, Araguas C, Gomez AJ, Ramirez S. Prevalence of phenotypic activated protein C resistance (APCR) in venous thromboembolic patients. Haematologica 1998; 83: 377–8.

    Google Scholar 

  28. Olave T, Cornudella R, Homs C, Azaceta G, Tirado I, Gutierrez M. Incidence and clinical manifestations of activated protein C resistance and factor V Leiden in young patients with venous thromboembolic disease in Spain. Haematologica 1998; 83: 378–80.

    Google Scholar 

  29. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698–703.

    Google Scholar 

  30. Raguenes O, Mercier B, Escoffre M, Traore L, Blouch MT, Robinet A et al. 1691 G to A mutation of the factor V gene: no association with thrombosis of the central retinal vein. Presse Med 1996; 25: 460.

    Google Scholar 

  31. Rath EZ, Frank RN, Shin DH, Kim C. Risk factors for retinal vein occlusions. A case-control study. Ophthalmology 1992; 99: 509–14.

    Google Scholar 

  32. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133–4.

    Google Scholar 

  33. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332: 912–7.

    Google Scholar 

  34. Rosendaal FR, Siscovick DS, Schwartz SM, Beverly RK, Psaty BM, Longstreth-WT J, et al. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood 1997; 89: 2817–21.

    Google Scholar 

  35. Samani NJ, Lodwick D, Martin D, Kimber P. Resistance to activated protein C and risk of premature myocardial infarction. Lancet 1994; 344: 1709–10.

    Google Scholar 

  36. Schröder W, Koesling M, Wulff K, Wehnert M, Herrmann FH. Large-scale screening for factor V Leiden mutation in a northeastern German population. Haemostasis 1996; 26: 233–6.

    Google Scholar 

  37. Ury HK, Fleiss JL. On approximate sample sizes for comparing two independent proportions with the use of Yates’ correction. Biometrics 1980; 36: 347–51.

    Google Scholar 

  38. van-der Meer FJ, Koster T, Vandenbroucke JP, Briet E, Rosendaal FR. The Leiden Thrombophilia Study (LETS). Thromb Haemost 1997; 78: 631–5.

    Google Scholar 

  39. Vandenbroucke JP, Koster T, Briet E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994; 344: 1453–7.

    Google Scholar 

  40. Vine AK, Samama MM. The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions. Surv Ophthalmol 1993; 37: 283–92.

    Google Scholar 

  41. Williamson TH, Rumley A, Lowe GD. Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study. Br J Ophthalmol 1996; 80: 203–8.

    Google Scholar 

  42. Witt I. APC-Resistenz (Faktor-V-Mutation). Klinische Bedeutung, Pathophysiologie und Diagnostik. Deutsches Ärzteblatt 1998; 38: 1815–20.

    Google Scholar 

  43. Zegarra H, Gutman FA, Conforto J. The natural course of central retinal vein occlusion. Ophthalmology 1979; 86: 1931–42.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Johannes-Gutenberg-University, Mainz, Germany

    Kathrin Greiner, Andrea Winkgen & Norbert Pfeiffer

  2. Department of Laboratory Medicine, Johannes-Gutenberg-University, Mainz, Germany

    Dirk Peetz, Winfried Prellwitz & Gerd Hafner

Authors
  1. Kathrin Greiner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dirk Peetz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrea Winkgen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Winfried Prellwitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Norbert Pfeiffer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gerd Hafner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Greiner, K., Peetz, D., Winkgen, A. et al. Genetic thrombophilia in patients with retinal vascular occlusion. Int Ophthalmol 23, 155–160 (1999). https://doi.org/10.1023/A:1010639332737

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1010639332737

Search

Navigation